AGER and chronic kidney disease: The cutoff values for lipocalin-2 and RAGE for predicting mortality were 62.48 ng/mL with sensitivity and specificity of 86% and 78% (area under the curve: 0.814; p = 0.007) and 8.5 ng/mL with sensitivity and specificity of 71% and 72% (area under the curve: 0.738; p = 0.04), respectively.<h4>Conclusion</h4>Biomarkers including lipocalin-2 and RAGE were assessed in this study and were found to have good predictive value for mortality outcomes in CKD.